Reports for Novaremed AG
Credit rating information
Evaluation of credit rating with traffic light as risk indicator and other helpful data about the company.Find out more
Economic information
Comprehensive information about the economic situation of a company.Find out more
Payment collection information
Overview of current and past debt enforcement proceedings.Find out more
Shareholder Information
Find out which national and international companies the stock corporation you are interested in also holds shares in.Find out more
Company dossier as PDF
Contact information, changes in the company, turnover and employee figures, management, ownership, shareholding structure and other company data.Retrieve company dossier
About Novaremed AG
- Novaremed AG with its legal headquarters in Basel is a Company limited by shares (AG) from the sector «Production of pharmaceutical substances». Novaremed AG is active.
- Novaremed AG was founded on 13.11.2017.
- The company has last modified its commercial register entry on 17.07.2025. All previous commercial register entries are available under «Notifications».
- The Enterprise Identification Number of the company Novaremed AG is the following: CHE-416.510.898.
- B Kappa AG, CareInvest AG, comm.versa GmbH have the same address as Novaremed AG.
Management (9)
newest board members
Dr. Thomas Meier,
Mark Altmeyer,
Andrew John Oakley,
Joseph Feinstein,
Limor Kohen
newest authorized signatories
Camilla Mittelholzer,
Dr. Thomas Meier,
Mark Altmeyer,
Andrew John Oakley,
Joseph Feinstein
Commercial register information
Entry in the commercial register
13.11.2017
Legal form
Company limited by shares (AG)
Legal headquarters of the company
Basel
Commercial Registry Office
BS
Commercial register number
CH-270.3.015.598-2
UID/VAT
CHE-416.510.898
Sector
Production of pharmaceutical substances
Purpose (Original language)
Die Gesellschaft bezweckt den Erwerb, die dauernde Verwaltung und die Veräusserung von Beteiligungen an Unternehmen aller Art im In- und Ausland. Die Gesellschaft kann daneben solche Unternehmen gründen, übernehmen und mit ihnen fusionieren. Sie kann Liegenschaften und Immaterialgüterrechte im In- und Ausland erwerben, belasten und veräussern sowie durch Beschluss des Verwaltungsrates Zweigniederlassungen und Agenturen im In- oder Ausland errichten.
Auditor
Current auditor (1)
| Name | City | Since | Until | |
|---|---|---|---|---|
| PricewaterhouseCoopers AG | Basel | 13.04.2018 | ||
Other company names
Past and translated company names
- Novaremed SA
- Novaremed Ltd
Branches (0)
Ownership structure
Holdings
Newest SOGC notifications: Novaremed AG
The latest updates from the Swiss Official Gazette of Commerce (SOGC) are available in the original language of the source commercial register office only. View all notifications
Publication number: HR02-1006387355, Commercial Registry Office Basel-Stadt, (270)
Novaremed AG, in Basel, CHE-416.510.898, Aktiengesellschaft (SHAB Nr. 103 vom 30.05.2025, Publ. 1006344578).
Statutenänderung:
08.07.2025.
Aktienkapital neu:
CHF 705'929.60 [bisher: CHF 705'455.00].
Liberierung Aktienkapital neu:
CHF 705'929.60 [bisher: CHF 705'455.00].
Aktien neu:
7'059'296 Namenaktien zu CHF 0.10 [bisher: 7'054'550 Namenaktien zu CHF 0.10]. Ordentliche Kapitalerhöhung innerhalb Kapitalband.
Publication number: HR02-1006344578, Commercial Registry Office Basel-Stadt, (270)
Novaremed AG, in Basel, CHE-416.510.898, Aktiengesellschaft (SHAB Nr. 63 vom 01.04.2025, Publ. 1006297004).
Statutenänderung:
07.05.2025.
Aktienkapital neu:
CHF 705'455.00 [bisher: CHF 699'369.20].
Liberierung Aktienkapital neu:
CHF 705'455.00 [bisher: CHF 699'369.20].
Aktien neu:
7'054'550 Namenaktien zu CHF 0.10 [bisher: 6'993'692 Namenaktien zu CHF 0.10]. Kapitalerhöhung aus bedingtem Aktienkapital. Ordentliche Kapitalerhöhung innerhalb Kapitalband.
Publication number: HR02-1006297004, Commercial Registry Office Basel-Stadt, (270)
Novaremed AG, in Basel, CHE-416.510.898, Aktiengesellschaft (SHAB Nr. 27 vom 10.02.2025, Publ. 1006252120).
Statutenänderung:
25.03.2025.
Aktienkapital neu:
CHF 699'369.20 [bisher: CHF 637'943.10].
Liberierung Aktienkapital neu:
CHF 699'369.20 [bisher: CHF 637'943.10].
Aktien neu:
6'993'692 Namenaktien zu CHF 0.10 [bisher: 6'379'431 Namenaktien zu CHF 0.10]. Ordentliche Kapitalerhöhung innerhalb Kapitalband.
Ausgeschiedene Personen und erloschene Unterschriften:
Piitulainen, Pasi Petteri, von Binningen, in Binningen, mit Kollektivunterschrift zu zweien.
Hit list
Here you will find a link from the management to a hit list of persons with the same name who are registered in the commercial register.